{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_topology","feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","contains":"claims, sources, anecdotes, question_graph slice","slug":"bpc-157-vs-nsaids","urls":{"read":"https://miscsubjects.com/api/articles/bpc-157-vs-nsaids/topology"},"how_to_use":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","write":null,"imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/bpc-157-vs-nsaids/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"ask","name":"Ask protocol","what":"Answer only from topology; creates question_node with gaps and ingest_hint.","urls":{"read":"https://miscsubjects.com/api/articles/bpc-157-vs-nsaids/prompts","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"graph_topology","name":"Cross-article graph","what":"Merged claims/sources across condition+stack slugs for one question.","urls":{"read":"https://miscsubjects.com/api/articles/bpc-157-vs-nsaids/graph-topology?question=..."}},{"id":"question_graph","name":"Question graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output).","urls":{"read":"https://miscsubjects.com/api/articles/bpc-157-vs-nsaids/question-graph","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","urls":{"read":"https://miscsubjects.com/api/articles/bpc-157-vs-nsaids/voxels","write":"https://miscsubjects.com/api/protocol/claim"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","why":"Every feature is auditable collective intelligence","how":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/bpc-157-vs-nsaids/topology"},"imessage":null,"router":null,"related":[{"id":"ask","what":"Answer only from topology; creates question_node with gaps and ingest_hint."},{"id":"graph_topology","what":"Merged claims/sources across condition+stack slugs for one question."},{"id":"question_graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output)."},{"id":"voxels","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance."}],"not_medical_advice":true},"slug":"bpc-157-vs-nsaids","title":"BPC-157 vs NSAIDs: Repair or Suppress?","register":"essay","tags":["bpc-157","nsaids","tendon","regeneration","disc"],"updated_at":"2026-08-08T18:38:00.019Z","body_excerpt":"An NSAID is the painkiller already in your cupboard: ibuprofen, naproxen, Advil, Nurofen, Aleve. It is sold over the counter, it is legal everywhere, and a packet costs a few pounds.\n\nBPC-157 is a lab-made copy of a small piece of a protein your own stomach makes. It arrives as a white powder in a sealed glass vial. You add liquid to it and inject it under the skin with an insulin needle. No pharmacy sells it, no country has approved it as a medicine, and everything on the market is labelled for research rather than for people.\n\n## How a torn tendon repairs itself\n\nA tendon is rope: bundles of collagen fibres running in parallel, anchored into bone at each end. Tear it and the body runs a sequence.\n\nFirst it swells. Swelling is not just the part that hurts — it is the opening instruction. The chemicals that make an injury hot and sore are the same chemicals that call in the cells that clear the wreckage and start laying down new rope.\n\nThen it rebuilds, and rebuilding runs on blood. Blood brings the oxygen and the repair cells. A tendon has very little blood running through it, far less than muscle, which is why a torn tendon takes months to heal and a torn muscle takes weeks.\n\nLast it re-anchors. Where tendon meets bone there is a gristly pad that grips one to the other. That pad is the weakest point of the whole repair and the place a healed tendon tears again.\n\nThree things decide how well you end up: whether the opening instruction is allowed to fire, how much blood reaches the damage, and whether that pad rebuilds properly. Everything below is what each of these two does to those three things.\n\n## What the painkiller does to it\n\nIt reduces the pain, and it does that reliably. Take ibuprofen 400 mg and roughly two people in every five get at least half their pain gone who would not have got it from a dummy pill. That figure comes from about 460 separate trials covering roughly 50,000 people, which makes it one of the better-established numbers in medicine.\n\nIt produces that relief by shutting down the swelling. That is the same swelling that is the opening instruction, so the relief and the interference are not two separate effects — they are one effect, seen from two ends.\n\nWhat that does to the tissue has been measured in rats. Both the newer and the older painkillers left a repaired tendon needing less force to tear off the bone again, and less stiff. The gristly pad at the bone was patchy and half-formed, where untreated animals had rebuilt it by four weeks. Giving the drug later does not avoid this: the damage showed up when it was given in the first five days, again at days 6 to 14, and again at days 11 to 20 after a repair.\n\nThe steroid injection is the stronger version of the same thing. It relieves for weeks to months, it changes where you end up a year later not at all, and it rebuilds nothing. What it buys is time before a decision about surgery.\n\nTaken for months rather than days, the painkillers carry their own bill: serious stomach bleeds and ulcers run about four times higher on ibuprofen and about four times higher again on naproxen, heart failure risk roughly doubles across the class, and for every thousand people taking one for a year there are three extra heart attacks or strokes, one of them fatal.\n\n## What BPC-157 does to it\n\nIt grows new blood vessels into damaged tissue. More vessels means more blood reaching the part of the repair that was starved of it — which is the second of the three things above, and the one a tendon is worst at.\n\nIn rats, a tendon cut clean off the heel bone and stitched back came away needing more force to tear again, stiffer, with the collagen fibres lying straight rather than scarred and more vessels grown into the join. The dose was 10 micrograms per kilo of body weight a day. About 150 animal studies exist and they point the same way. In two of them it undid damage a steroid injection had already done to a healing tendon.\n\nIn people it has been given in five studies, abou","ranking":"safety-first (interaction_risk/limitations), then quote-gated effective_weight","claims":[{"id":"c30","text":"In September 2023 the FDA put BPC-157 in Category 2 of the 503A bulk substances list, which barred pharmacies from compounding it.","tier":"mechanistic","section":"Where BPC-157 stands with the FDA, WADA and the US military","slot":"limitations","interaction_risk":false,"status":"active","source_ids":[],"source_status":"GAP: the FDA Category 2 record and the July 2026 advisory committee documents are cited in the body but are not registered as source objects on this article; the corresponding sources exist on the sibling objects wolverine-stack (s31, s32) and what-are-peptides-herniated-disc (s32).","why_material":"The regulatory position moved four times in three years, so the dates carry the meaning rather than the summary.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.3,"quote_gated":false},{"id":"c31","text":"WADA's 2026 Prohibited List names BPC-157 under S0, its non-approved substances category, banned both in and out of competition.","tier":"mechanistic","section":"Where BPC-157 stands with the FDA, WADA and the US military","slot":"limitations","interaction_risk":false,"status":"active","source_ids":[],"source_status":"GAP: the WADA 2026 Prohibited List and the DoD list are cited in the body but not registered as source objects on this article; the WADA list is attached on the sibling object wolverine-stack (s33).","why_material":"For a tested athlete this decides the comparison regardless of effect size.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.3,"quote_gated":false},{"id":"c330","text":"By the 14 May 2026 revision it had come off all three categories, because the nominations behind it were withdrawn.","tier":"mechanistic","section":"Where BPC-157 stands with the FDA, WADA and the US military","slot":"limitations","interaction_risk":false,"status":"active","source_ids":[],"source_status":"GAP: the FDA Category 2 record and the July 2026 advisory committee documents are cited in the body but are not registered as source objects on this article; the corresponding sources exist on the sibling objects wolverine-stack (s31, s32) and what-are-peptides-herniated-disc (s32).","why_material":"The regulatory position moved four times in three years, so the dates carry the meaning rather than the summary.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.3,"quote_gated":false},{"id":"c331","text":"In July 2026 the FDA's own briefing document recommended against adding it back.","tier":"mechanistic","section":"Where BPC-157 stands with the FDA, WADA and the US military","slot":"limitations","interaction_risk":false,"status":"active","source_ids":[],"source_status":"GAP: the FDA Category 2 record and the July 2026 advisory committee documents are cited in the body but are not registered as source objects on this article; the corresponding sources exist on the sibling objects wolverine-stack (s31, s32) and what-are-peptides-herniated-disc (s32).","why_material":"The regulatory position moved four times in three years, so the dates carry the meaning rather than the summary.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.3,"quote_gated":false},{"id":"c332","text":"On 23 July 2026 the Pharmacy Compounding Advisory Committee voted 8 to 6, with one abstention, to recommend adding it anyway, against the FDA staff position.","tier":"mechanistic","section":"Where BPC-157 stands with the FDA, WADA and the US military","slot":"limitations","interaction_risk":false,"status":"active","source_ids":[],"source_status":"GAP: the FDA Category 2 record and the July 2026 advisory committee documents are cited in the body but are not registered as source objects on this article; the corresponding sources exist on the sibling objects wolverine-stack (s31, s32) and what-are-peptides-herniated-disc (s32).","why_material":"The regulatory position moved four times in three years, so the dates carry the meaning rather than the summary.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.3,"quote_gated":false},{"id":"c333","text":"It is not on the 503B list either.","tier":"mechanistic","section":"Where BPC-157 stands with the FDA, WADA and the US military","slot":"limitations","interaction_risk":false,"status":"active","source_ids":[],"source_status":"GAP: the FDA Category 2 record and the July 2026 advisory committee documents are cited in the body but are not registered as source objects on this article; the corresponding sources exist on the sibling objects wolverine-stack (s31, s32) and what-are-peptides-herniated-disc (s32).","why_material":"The regulatory position moved four times in three years, so the dates carry the meaning rather than the summary.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.3,"quote_gated":false},{"id":"c334","text":"The US Department of Defense puts it on its Prohibited Dietary Supplement Ingredients List and says plainly that it is not a dietary ingredient but an unapproved drug, by any route.","tier":"mechanistic","section":"Where BPC-157 stands with the FDA, WADA and the US military","slot":"limitations","interaction_risk":false,"status":"active","source_ids":[],"source_status":"GAP: the WADA 2026 Prohibited List and the DoD list are cited in the body but not registered as source objects on this article; the WADA list is attached on the sibling object wolverine-stack (s33).","why_material":"For a tested athlete this decides the comparison regardless of effect size.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.3,"quote_gated":false},{"id":"c335","text":"Research-use-only printed on a vial is a shipping label, not a permission.","tier":"mechanistic","section":"Where BPC-157 stands with the FDA, WADA and the US military","slot":"limitations","interaction_risk":false,"status":"active","source_ids":[],"source_status":"GAP: the WADA 2026 Prohibited List and the DoD list are cited in the body but not registered as source objects on this article; the WADA list is attached on the sibling object wolverine-stack (s33).","why_material":"For a tested athlete this decides the comparison regardless of effect size.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.3,"quote_gated":false},{"id":"c3","text":"In people, dripping an anti-inflammatory into a working muscle wiped out the rise in satellite cells that exercise normally produces. Those are the stem cells that rebuild muscle.","tier":"human","section":"In people, an anti-inflammatory switched off the muscle stem cells that exercise calls up","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s7"],"why_material":"Direct human evidence NSAIDs blunt the stem-cell repair response.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c5","text":"The picture in people is contested. A meta-analysis that adjusted for confounders found no significant rise in fractures failing to knit among people taking these drugs.","tier":"human","section":"In human fracture patients the healing harm has not turned up","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s5","s4"],"why_material":"Honest counterweight — the strong preclinical signal does not cleanly translate to human fracture outcomes.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c6","text":"Taking these drugs for years brings a well-established risk of bleeding and ulcers in the gut, and the risk climbs with the dose.","tier":"human","section":"Years of anti-inflammatories bleed the gut, and which one you take matters","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s15"],"why_material":"The best-documented real harm of the suppression approach, on an undisputed human endpoint.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c10","text":"For sudden muscle and joint pain the anti-inflammatories are still the first thing the guidelines reach for, and they earned that.","tier":"human","section":"The anti-inflammatories earned their place for sudden muscle and joint pain","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s16"],"why_material":"Prevents a straw-man contrast: NSAIDs are effective analgesics; the critique is about long-term repair, not acute pain control.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c11","text":"A Cochrane overview gathered up 39 systematic reviews, covering roughly 460 randomised trials and about 50,000 people who had taken a painkiller.","tier":"human","section":"Ibuprofen carries tens of thousands of trial participants and BPC-157 carries none","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s23"],"why_material":"The scale asymmetry between the drug and the peptide is the page's opening fact, and it does not favour the peptide.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c12","text":"BPC-157 has never finished a randomised controlled trial in a human being for any injury at all. Not tendon, not muscle, not disc, not joint.","tier":"human","section":"Ibuprofen carries tens of thousands of trial participants and BPC-157 carries none","slot":"what_is_unknown","interaction_risk":false,"status":"active","source_ids":["s10","s11","s12"],"why_material":"The absence is the central fact about the peptide side of the comparison.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c13","text":"For sudden low back pain, Cochrane pooled 32 trials and 5,356 people and found the anti-inflammatories took 7.29 points off pain on a 0 to 100 scale (95% CI -10.98 to -3.61, moderate quality).","tier":"human","section":"For back pain the anti-inflammatories beat placebo by a few points and exercise beats them","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s21"],"why_material":"The drug's advantage over the peptide narrows sharply in the condition most readers arrive with.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c14","text":"For back pain that has dragged on, Cochrane pooled 13 trials and the anti-inflammatories beat placebo by 3.30 points on a 0 to 100 scale (95% CI -5.33 to -1.27, low quality).","tier":"human","section":"For back pain the anti-inflammatories beat placebo by a few points and exercise beats them","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s22"],"why_material":"An effect that shrinks as bias is removed is the signature of an effect that may not be there.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c15","text":"Structured exercise, pooled across 249 randomised trials, took 15.2 points off long-running low back pain and cleared the bar the reviewers had set in advance for a difference that matters.","tier":"human","section":"For back pain the anti-inflammatories beat placebo by a few points and exercise beats them","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s24"],"why_material":"Ranks all three options on the same scale, which is the only way the comparison is honest.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c16","text":"One analysis went back to the individual patients in 280 placebo-controlled trials covering 124,513 people, plus 474 head-to-head trials covering 229,296 more.","tier":"human","section":"Naproxen and ibuprofen roughly quadruple the odds of a bleed at the top of the gut","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s18"],"why_material":"Naproxen, usually recommended as the heart-safe choice, carries the worst gut number in the set.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c17","text":"The PRECISION trial put 24,081 people who had arthritis and a raised heart risk onto celecoxib, ibuprofen or naproxen for an average of 20 months.","tier":"human","section":"Naproxen and ibuprofen roughly quadruple the odds of a bleed at the top of the gut","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s19"],"why_material":"A head-to-head randomised trial confirming the direction of the observational gut data.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c18","text":"In that same 124,513-person analysis, major events in the blood vessels came out 1.37 times more likely on the coxibs, 1.41 times on diclofenac and 1.44 times on ibuprofen, which did not reach significance, with naproxen sitting at 0.93.","tier":"human","section":"Every anti-inflammatory except naproxen raised events in the blood vessels, and all of them raised heart failure","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s18"],"why_material":"There is no free option; the heart and gut tables point in opposite directions drug by drug.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c19","text":"Forty studies covering 1,757,118 people found that taking anti-inflammatories long term raised the odds of getting long-running kidney disease, or of making existing kidney disease worse.","tier":"human","section":"Years of anti-inflammatories raised the odds of kidney disease by about half","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s20"],"why_material":"The third measured organ harm, and the one that scales with duration rather than dose.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c23","text":"The one human experiment in this group ran the same test in reverse. An anti-inflammatory dripped straight into working muscle wiped out the rise in satellite cells that loading normally produces.","tier":"human","section":"The animal tendon and bone experiments behind the anti-inflammatory healing worry","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s7"],"why_material":"The only direct human demonstration that the drug reaches and blunts a repair signal.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c24","text":"Against all of that, a meta-analysis of human fracture outcomes that adjusted for confounders found no significant rise in fractures failing to knit among people on these drugs.","tier":"human","section":"The animal tendon and bone experiments behind the anti-inflammatory healing worry","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s5","s4"],"why_material":"The counter-evidence is real and is stated at the same weight as the case it opposes.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c25","text":"In animal work, steroids held the herniated disc back from shrinking away on its own.","tier":"human","section":"With a herniated disc, the one series that withheld anti-inflammatories saw every disc shrink","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s17"],"why_material":"The only place where suppressing inflammation may work directly against the mechanism that resolves the condition.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c32","text":"The healing harm from the anti-inflammatories reproduces consistently in animals.","tier":"human","section":"The fair verdict on BPC-157 against the anti-inflammatories, stated as a rate","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s1","s3","s5","s6","s7"],"why_material":"This is the page's single contested conclusion and it is written so that either overstatement — that the drugs wreck human healing, or that the concern is invented — is refuted by the same sentence.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c302","text":"Human bone stem cells also turn out to be less sensitive to these drugs than rat cells are.","tier":"human","section":"In human fracture patients the healing harm has not turned up","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s5","s4"],"why_material":"Honest counterweight — the strong preclinical signal does not cleanly translate to human fracture outcomes.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c303","text":"Which one you take matters a great deal. Ketorolac runs about 20 times the risk, and celecoxib is the lowest of the group.","tier":"human","section":"Years of anti-inflammatories bleed the gut, and which one you take matters","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s15"],"why_material":"The best-documented real harm of the suppression approach, on an undisputed human endpoint.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c306","text":"On that evidence, ibuprofen 400 mg clears at least 50% of the pain in one extra person for every 2.5 people who take it.","tier":"human","section":"Ibuprofen carries tens of thousands of trial participants and BPC-157 carries none","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s23"],"why_material":"The scale asymmetry between the drug and the peptide is the page's opening fact, and it does not favour the peptide.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c307","text":"Fast-acting ibuprofen 200 mg brings that number down to 2.1, and ibuprofen 200 mg taken with paracetamol 500 mg brings it to 1.6.","tier":"human","section":"Ibuprofen carries tens of thousands of trial participants and BPC-157 carries none","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s23"],"why_material":"The scale asymmetry between the drug and the peptide is the page's opening fact, and it does not favour the peptide.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c308","text":"What exists instead is rat work, a handful of early safety studies in people for other conditions, and what people say happened to them.","tier":"human","section":"Ibuprofen carries tens of thousands of trial participants and BPC-157 carries none","slot":"what_is_unknown","interaction_risk":false,"status":"active","source_ids":["s10","s11","s12"],"why_material":"The absence is the central fact about the peptide side of the comparison.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c309","text":"Disability moved 2.02 points on a 0 to 24 scale, and the reviewers called both of those effects small and probably not meaningful to the person feeling them.","tier":"human","section":"For back pain the anti-inflammatories beat placebo by a few points and exercise beats them","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s21"],"why_material":"The drug's advantage over the peptide narrows sharply in the condition most readers arrive with.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c310","text":"Disability moved 0.85 points on a 0 to 24 scale, and when the reviewers kept only the trials at low risk of bias, the gap shrank further.","tier":"human","section":"For back pain the anti-inflammatories beat placebo by a few points and exercise beats them","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s22"],"why_material":"An effect that shrinks as bias is removed is the signature of an effect that may not be there.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c311","text":"That is roughly double what the drugs managed for sudden back pain, and nearly five times what they managed for the long-running kind.","tier":"human","section":"For back pain the anti-inflammatories beat placebo by a few points and exercise beats them","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s24"],"why_material":"Ranks all three options on the same scale, which is the only way the comparison is honest.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c312","text":"Serious trouble at the top of the gut came out 4.22 times more likely on naproxen, 3.97 times on ibuprofen, 1.89 times on diclofenac and 1.81 times on the coxibs.","tier":"human","section":"Naproxen and ibuprofen roughly quadruple the odds of a bleed at the top of the gut","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s18"],"why_material":"Naproxen, usually recommended as the heart-safe choice, carries the worst gut number in the set.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c313","text":"Gut events came out significantly lower on celecoxib than on naproxen (p = 0.01) or on ibuprofen (p = 0.002).","tier":"human","section":"Naproxen and ibuprofen roughly quadruple the odds of a bleed at the top of the gut","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s19"],"why_material":"A head-to-head randomised trial confirming the direction of the observational gut data.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c314","text":"Heart failure risk was roughly doubled by every one of them.","tier":"human","section":"Every anti-inflammatory except naproxen raised events in the blood vessels, and all of them raised heart failure","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s18"],"why_material":"There is no free option; the heart and gut tables point in opposite directions drug by drug.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c315","text":"Put as plain counts, for every 1,000 people who take a coxib or diclofenac for a year, three have an extra major blood vessel event and one of those three dies of it.","tier":"human","section":"Every anti-inflammatory except naproxen raised events in the blood vessels, and all of them raised heart failure","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s18"],"why_material":"There is no free option; the heart and gut tables point in opposite directions drug by drug.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c316","text":"The pooled odds ratio came out at 1.24 and the pooled hazard ratio at 1.50, rising to 1.67 in people whose kidneys were already damaged.","tier":"human","section":"Years of anti-inflammatories raised the odds of kidney disease by about half","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s20"],"why_material":"The third measured organ harm, and the one that scales with duration rather than dose.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c320","text":"Human bone stem cells put side by side with rat ones leaned far less on COX-2, which is a species-level reason the animal result may not carry over.","tier":"human","section":"The animal tendon and bone experiments behind the anti-inflammatory healing worry","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s5","s4"],"why_material":"The counter-evidence is real and is stated at the same weight as the case it opposes.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c321","text":"A clinical series that deliberately withheld anti-inflammatory drugs reported the disc shrinking away on its own in every single patient.","tier":"human","section":"With a herniated disc, the one series that withheld anti-inflammatories saw every disc shrink","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s17"],"why_material":"The only place where suppressing inflammation may work directly against the mechanism that resolves the condition.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c322","text":"That was a case series and not a randomised trial, and it should carry only the weight a case series carries.","tier":"human","section":"With a herniated disc, the one series that withheld anti-inflammatories saw every disc shrink","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s17"],"why_material":"The only place where suppressing inflammation may work directly against the mechanism that resolves the condition.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c336","text":"In people, the repair signals measured at the cell level are measurably blunted.","tier":"human","section":"The fair verdict on BPC-157 against the anti-inflammatories, stated as a rate","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s1","s3","s5","s6","s7"],"why_material":"This is the page's single contested conclusion and it is written so that either overstatement — that the drugs wreck human healing, or that the concern is invented — is refuted by the same sentence.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c337","text":"In people, the healing outcomes that actually get measured in a clinic show no proven harm.","tier":"human","section":"The fair verdict on BPC-157 against the anti-inflammatories, stated as a rate","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s1","s3","s5","s6","s7"],"why_material":"This is the page's single contested conclusion and it is written so that either overstatement — that the drugs wreck human healing, or that the concern is invented — is refuted by the same sentence.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c1","text":"In controlled animal experiments, the anti-inflammatories and the COX-2 blockers hold back tendon-to-bone healing, and the repair stays weaker for weeks afterwards.","tier":"preclinical","section":"Anti-inflammatory drugs weaken healing tendon and bone in animals","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s1","s3","s2"],"why_material":"Core degenerative-permissive claim: the drug suppresses the healing response, not just pain.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.5,"quote_gated":false},{"id":"c4","text":"Animal fracture experiments pooled together show these drugs leave healing bone measurably weaker.","tier":"preclinical","section":"Anti-inflammatory drugs weaken healing tendon and bone in animals","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s6"],"why_material":"Extends the suppression thesis from tendon and muscle to bone.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.5,"quote_gated":false},{"id":"c7","text":"In rat tendon experiments BPC-157 pushes repair forward, so the tendon carries more load before it fails and lays down better collagen.","tier":"preclinical","section":"What BPC-157 does in rats is the opposite of what the anti-inflammatories do","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s10","s11"],"why_material":"The regenerative pole: BPC-157 is studied for building tissue, the opposite intent from suppressing repair.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.5,"quote_gated":false},{"id":"c9","text":"In rat poisoning experiments, BPC-157 undoes the gut and organ damage that the anti-inflammatory drugs cause.","tier":"preclinical","section":"What BPC-157 does in rats is the opposite of what the anti-inflammatories do","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s13","s14"],"why_material":"Ties the two subjects together - BPC-157 is studied as protection against the exact GI damage NSAIDs cause.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.5,"quote_gated":false},{"id":"c20","text":"In an animal rotator cuff repair, both indomethacin and celecoxib left the tendon-to-bone join significantly weaker than in untreated animals, and it was still weaker out at eight weeks.","tier":"preclinical","section":"The animal tendon and bone experiments behind the anti-inflammatory healing worry","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s1"],"why_material":"The animal healing impairment is specific to the tissue people take these drugs for.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.5,"quote_gated":false},{"id":"c21","text":"Ibuprofen given in the first days after the injury measurably worsens tendon healing, while the same drug given later on does not.","tier":"preclinical","section":"The animal tendon and bone experiments behind the anti-inflammatory healing worry","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s3"],"why_material":"The timing dependence is the strongest part of the healing-impairment case because it discriminates between two competing explanations.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.5,"quote_gated":false},{"id":"c22","text":"Mice bred without the COX-2 enzyme heal fractures badly, and putting the downstream prostaglandin E2 signal back rescues that healing.","tier":"preclinical","section":"The animal tendon and bone experiments behind the anti-inflammatory healing worry","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s8","s6"],"why_material":"Establishes the impairment as mechanistic rather than incidental.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.5,"quote_gated":false},{"id":"c26","text":"A rat Achilles tendon cut clean through and then given BPC-157 took more load before it failed, and laid down better-organised collagen than the untreated tendons did.","tier":"preclinical","section":"What BPC-157 actually has behind it, which is rats","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s10","s11"],"why_material":"The strongest thing the peptide has, and it is entirely rodent.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.5,"quote_gated":false},{"id":"c27","text":"BPC-157 raises VEGF and drives new blood vessels into healing muscle and tendon, which is the same pathway that blocking COX-2 shuts down.","tier":"preclinical","section":"What BPC-157 actually has behind it, which is rats","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s12","s13","s14"],"why_material":"The two compounds act on the same axis in opposite directions, which is the actual structure of the comparison.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.5,"quote_gated":false},{"id":"c300","text":"The damage is worst when the drug is given in the first days, while the body is still setting the repair up.","tier":"preclinical","section":"Anti-inflammatory drugs weaken healing tendon and bone in animals","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s1","s3","s2"],"why_material":"Core degenerative-permissive claim: the drug suppresses the healing response, not just pain.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.5,"quote_gated":false},{"id":"c304","text":"The tendon cells themselves grow out further, survive longer and travel further to the injury when BPC-157 is there.","tier":"preclinical","section":"What BPC-157 does in rats is the opposite of what the anti-inflammatories do","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s10","s11"],"why_material":"The regenerative pole: BPC-157 is studied for building tissue, the opposite intent from suppressing repair.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.5,"quote_gated":false},{"id":"c317","text":"That timing is exactly the pattern you would expect if the drug is interrupting the instruction to repair rather than just muffling the pain.","tier":"preclinical","section":"The animal tendon and bone experiments behind the anti-inflammatory healing worry","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s3"],"why_material":"The timing dependence is the strongest part of the healing-impairment case because it discriminates between two competing explanations.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.5,"quote_gated":false},{"id":"c318","text":"So the enzyme these drugs exist to block is the same enzyme the repair itself runs on.","tier":"preclinical","section":"The animal tendon and bone experiments behind the anti-inflammatory healing worry","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s8","s6"],"why_material":"Establishes the impairment as mechanistic rather than incidental.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.5,"quote_gated":false},{"id":"c319","text":"Pooled animal data separately show the drugs cut the mechanical strength of a healing fracture.","tier":"preclinical","section":"The animal tendon and bone experiments behind the anti-inflammatory healing worry","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s8","s6"],"why_material":"Establishes the impairment as mechanistic rather than incidental.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.5,"quote_gated":false},{"id":"c323","text":"The tendon cells also grew out further, survived longer and travelled further, which are the three behaviours that mark active repair rather than simply scarring over.","tier":"preclinical","section":"What BPC-157 actually has behind it, which is rats","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s10","s11"],"why_material":"The strongest thing the peptide has, and it is entirely rodent.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.5,"quote_gated":false},{"id":"c324","text":"Given alongside diclofenac in rats, BPC-157 undid the gut, liver and brain damage the drug had caused.","tier":"preclinical","section":"What BPC-157 actually has behind it, which is rats","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s12","s13","s14"],"why_material":"The two compounds act on the same axis in opposite directions, which is the actual structure of the comparison.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.5,"quote_gated":false},{"id":"c325","text":"In a further rat experiment it handled induced arthritis and the drug's gut damage at the same time.","tier":"preclinical","section":"What BPC-157 actually has behind it, which is rats","slot":"what_is_known","interaction_risk":false,"status":"active","source_ids":["s12","s13","s14"],"why_material":"The two compounds act on the same axis in opposite directions, which is the actual structure of the comparison.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.5,"quote_gated":false},{"id":"c2","text":"This is not an odd side effect. The repair phase of healing runs on the COX-2 enzyme, and blocking that enzyme is the whole reason the anti-inflammatories work.","tier":"mechanistic","section":"Anti-inflammatory drugs weaken healing tendon and bone in animals","slot":"what_it_is","interaction_risk":false,"status":"active","source_ids":["s8","s9","s2"],"why_material":"Shows the same pathway makes the pain signal and drives repair, so blocking one blocks the other.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.3,"quote_gated":false},{"id":"c8","text":"Part of how BPC-157 works is driving new blood vessel growth into the injury through a signal called VEGF.","tier":"mechanistic","section":"What BPC-157 does in rats is the opposite of what the anti-inflammatories do","slot":"what_it_is","interaction_risk":false,"status":"active","source_ids":["s12","s8"],"why_material":"Sharpest contrast: the two agents act on the same repair machinery in opposite directions.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.3,"quote_gated":false},{"id":"c301","text":"Putting the downstream signal back, prostaglandin E2 acting on its EP4 receptor, restores the healing the drug had taken away.","tier":"mechanistic","section":"Anti-inflammatory drugs weaken healing tendon and bone in animals","slot":"what_it_is","interaction_risk":false,"status":"active","source_ids":["s8","s9","s2"],"why_material":"Shows the same pathway makes the pain signal and drives repair, so blocking one blocks the other.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.3,"quote_gated":false},{"id":"c305","text":"That is the same blood vessel pathway that blocking COX-2 shuts down during healing.","tier":"mechanistic","section":"What BPC-157 does in rats is the opposite of what the anti-inflammatories do","slot":"what_it_is","interaction_risk":false,"status":"active","source_ids":["s12","s8"],"why_material":"Sharpest contrast: the two agents act on the same repair machinery in opposite directions.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.3,"quote_gated":false},{"id":"c28","text":"Seven people wrote first-hand about taking anti-inflammatories for years, and 4 of them described a harm.","tier":"anecdotal","section":"Seven people on long-term anti-inflammatories, counted","slot":"who_claims_what","interaction_risk":false,"status":"active","source_ids":["s25","s26","s27","s28","s29","s30","s31"],"why_material":"The panel shows what the harm looks like when it lands, and the page states explicitly that it does not show how often it lands.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.3,"quote_gated":false},{"id":"c29","text":"Ten people wrote first-hand about using BPC-157. 6 said it helped, 1 said it helped and raised the placebo question himself, 2 said it did nothing, and 1 gave no outcome either way.","tier":"anecdotal","section":"Ten people on BPC-157, counted","slot":"who_claims_what","interaction_risk":false,"status":"active","source_ids":["s32","s33","s34","s35","s36","s37","s38","s39","s40","s41"],"why_material":"The declared selection problem in two of six positive accounts is part of the count rather than a footnote to it.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.3,"quote_gated":false},{"id":"c326","text":"Of the other three, 1 had been warned off by a doctor without anything having gone wrong yet, 1 had gone more than ten years with no problems, and 1 was worried and waiting on tests.","tier":"anecdotal","section":"Seven people on long-term anti-inflammatories, counted","slot":"who_claims_what","interaction_risk":false,"status":"active","source_ids":["s25","s26","s27","s28","s29","s30","s31"],"why_material":"The panel shows what the harm looks like when it lands, and the page states explicitly that it does not show how often it lands.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.3,"quote_gated":false},{"id":"c327","text":"The share who came to harm in that small group is not the rate in the population, which is roughly a 4-fold relative increase on a small absolute base.","tier":"anecdotal","section":"Seven people on long-term anti-inflammatories, counted","slot":"who_claims_what","interaction_risk":false,"status":"active","source_ids":["s25","s26","s27","s28","s29","s30","s31"],"why_material":"The panel shows what the harm looks like when it lands, and the page states explicitly that it does not show how often it lands.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.3,"quote_gated":false},{"id":"c328","text":"Nobody in that group reported serious harm, and the only physical complaint was soreness at an injection site.","tier":"anecdotal","section":"Ten people on BPC-157, counted","slot":"who_claims_what","interaction_risk":false,"status":"active","source_ids":["s32","s33","s34","s35","s36","s37","s38","s39","s40","s41"],"why_material":"The declared selection problem in two of six positive accounts is part of the count rather than a footnote to it.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.3,"quote_gated":false},{"id":"c329","text":"Two of the six accounts that said it helped carry a supplier link or a follow-me pitch.","tier":"anecdotal","section":"Ten people on BPC-157, counted","slot":"who_claims_what","interaction_risk":false,"status":"active","source_ids":["s32","s33","s34","s35","s36","s37","s38","s39","s40","s41"],"why_material":"The declared selection problem in two of six positive accounts is part of the count rather than a footnote to it.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.3,"quote_gated":false}],"sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/16210573/","title":"Indomethacin and celecoxib impair rotator cuff tendon-to-bone healing","quote":"There were significantly lower failure loads in the celecoxib and indomethacin groups compared with the control groups at 2, 4, and 8 weeks (P < .001)","claim_ids":["c1"],"hash":"10da630fc7b601f4e04d5c233d11a3a69bd00d235fa0298be3c7c44d81e0e287"},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3764618/","title":"NSAID therapy effects on healing of bone, tendon, and the enthesis","quote":"Numerous animal studies have demonstrated a consistent negative effect of NSAID treatment on endochondral ossification during fracture healing.","claim_ids":["c1","c2"],"hash":"6195401ea20a004f528db3a4648bc3e5bdaae4300692e115db96c363cd9ba55e"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/23982408/","title":"The detrimental effects of systemic Ibuprofen delivery on tendon healing are time-dependent","quote":"Early administration of ibuprofen in the postoperative period was detrimental to tendon healing, while delayed administration did not affect tendon healing.","claim_ids":["c1"],"hash":"74343a921af7d7ca56c561126b2a0b5c0b879216a1645d3002c337f7c5490f28"},{"id":"s4","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9454294/","title":"Cross-species comparisons reveal resistance of human skeletal stem cells to inhibition by NSAIDs","quote":"human SSCs (hSSC) downregulated COX2 expression during differentiation and showed impaired osteogenic capacity if COX2 was lentivirally overexpressed.","claim_ids":["c5"],"hash":"2ee1555d35e7e147f911fafc04b1cfcf10a2afece99ab0b68223c93e3bd0fb5a"},{"id":"s5","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11420001/","title":"Do NSAIDs affect bone healing rate, delay union, or cause non-union: an updated systematic review and meta-analysis","quote":"There was no significant difference in the rates of non-union or delayed union between NSAID users and non-users (pooled adjusted OR = 1.11; 95% CI: 0.99-1.23)","claim_ids":["c5"],"hash":"7df8e5ef9212a17f9ec542dd54184e732aba2ff78956e6382e4b5507ed9f1760"},{"id":"s6","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8268344/","title":"NSAIDs and bone healing in animal models - a systematic review and meta-analysis","quote":"NSAIDs administration decreased the biomechanical properties of healing bones after fracture surgery in comparison to the control group.","claim_ids":["c4"],"hash":"86964d7982aa69758288590a722827197fcfe6aa485c4a682cecb28cc7e6717b"},{"id":"s7","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/19713429/","title":"Local NSAID infusion inhibits satellite cell proliferation in human skeletal muscle after eccentric exercise","quote":"The number of Pax7(+) cells was unchanged in the leg muscles exposed to the NSAID (0.07 +/- 0.01).","claim_ids":["c3"],"hash":"aefb763b1c62b75f28cc439c6e8fcb7be27c6ec7ab39320d8e5e3e3af4230814"},{"id":"s8","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/19628768/","title":"Rescue of impaired fracture healing in COX-2-/- mice via activation of prostaglandin E2 receptor subtype 4","quote":"The EP4 agonist markedly improved the impaired healing in COX-2(-/-) mice ... a near complete reversal of bone formation","claim_ids":["c2","c8"],"hash":"d36bdc9fe8e9ef04d333908313d8468a860c31628d3b1f89311c599df771ff44"},{"id":"s9","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3276605/","title":"Reduced COX-2 Expression in Aged Mice Is Associated With Impaired Fracture Healing","quote":"Cyclooxygenase 2 (COX-2), the inducible regulator of prostaglandin E2 (PGE2) synthesis, is critical for normal bone repair.","claim_ids":["c2"],"hash":"23bb5491d06eb0cf4c86d4a2b520003cf834f3efa837c3bb6b5e43832cca3df8"},{"id":"s10","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/14554208/","title":"Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and stimulates tendocyte growth in vitro","quote":"pentadecapeptide BPC 157 fully improves recovery: (i) biomechanically, increased load of failure, load of failure per area and Young's modulus of elasticity","claim_ids":["c7"],"hash":"51af90a8551727df67ac6f100b86c4ec290e6c9a147572f62d9c2d6a878bf448"},{"id":"s11","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/21030672/","title":"The promoting effect of BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration","quote":"BPC 157 promotes the ex vivo outgrowth of tendon fibroblasts from tendon explants, cell survival under stress, and the in vitro migration","claim_ids":["c7"],"hash":"f5a5a3fa3b4a384fdb185c63f9cc02f2a01d82af3f771b4f4111acee69109587"},{"id":"s12","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/20388964/","title":"Modulatory effect of BPC 157 on angiogenesis in muscle and tendon healing","quote":"BPC 157 stimulating angiogenesis by up-regulating VEGF expression.","claim_ids":["c8"],"hash":"1e821859ff8033f26ee51fba6a6e95a63cd8e6a6b64becf4bd6d64cee299bed2"},{"id":"s13","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/21295044/","title":"BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced GI, liver, and encephalopathy lesions","quote":"may encourage its further use as a therapy to counteract diclofenac- and other NSAID-induced toxicity.","claim_ids":["c9"],"hash":"5fbbe156c48418182f0dca535b2675e495b4b0b806ff14284bacb3e216e8c615"},{"id":"s14","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/9403784/","title":"BPC 157 positively affects both NSAID-induced gastrointestinal lesions and adjuvant arthritis in rats","quote":"Given with the investigated NSAIAs, BPC 157 consistently reduced the otherwise prominent lesions in the stomach ... as well as the lesions in the small intestine","claim_ids":["c9"],"hash":"6fb170120e1fc87c2916ae58eef04c02d037ae582d8fb041776a1ee80bc556b5"},{"id":"s15","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12746519/","title":"NSAIDs and Risk of Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis","quote":"ketorolac showed the highest risk (OR 20.67, 95% CI: 14.56-29.34)","claim_ids":["c6"],"hash":"6fca5f2bbe021a787908a14f4ef6d0cf07bdada5db95b0a3c7ba941bb95f5fe8"},{"id":"s16","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/32805126/","title":"Management of Acute Pain From Non-Low Back Musculoskeletal Injuries: ACP/AAFP Clinical Guideline","quote":"clinicians treat patients with acute pain from non-low back, musculoskeletal injuries with topical nonsteroidal anti-inflammatory drugs (NSAIDs) ... as first-line therapy","claim_ids":["c10"],"hash":"e5642db09702f30980489b03f51dcd5b255fa521872e075ccc96fc9b2e5fa607"},{"id":"s17","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12890389/","title":"Lumbar Disc Herniation Resorption: When and How Does It Occur?","quote":"controlled inflammatory responses are necessary for disc resorption ... standard anti-inflammatory treatments may paradoxically impede this process.","claim_ids":[],"hash":"378dbfe65853810dd9873a4585304fbc9dd591b7a22b93550450126156150232"},{"id":"s18","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/23726390/","title":"Vascular and upper gastrointestinal effects of NSAIDs: meta-analyses of individual participant data from randomised trials (Lancet 2013, PMID 23726390)","quote":"Major vascular events were increased by about a third by a coxib (rate ratio [RR] 1.37) or diclofenac (1.41)... Ibuprofen also significantly increased major coronary events (2.22), but not major vascular events (1.44). Naproxen did not significantly increase major vascular events (0.93)... Heart failure risk was roughly doubled by all NSAIDs. All NSAID regimens increased upper gastrointestinal complications (coxibs 1.81; diclofenac 1.89; ibuprofen 3.97; and naproxen 4.22).","summary":"280 placebo-controlled trials (124,513 participants) plus 474 head-to-head trials (229,296). The definitive per-drug harm table for heart, heart failure and upper gut.","claim_ids":[],"hash":"0bd5346b10c72b3118276aa39003dbc0293e6548e28d52e1e824a030d4e6a0ce"},{"id":"s19","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/27959716/","title":"Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis — PRECISION (NEJM 2016, PMID 27959716)","quote":"A total of 24,081 patients were randomly assigned to the celecoxib group... the naproxen group... or the ibuprofen group for a mean treatment duration of 20.3 months... The risk of gastrointestinal events was significantly lower with celecoxib than with naproxen (P=0.01) or ibuprofen (P=0.002); the risk of renal events was significantly lower with celecoxib than with ibuprofen (P=0.004)... At moderate doses, celecoxib was found to be noninferior to ibuprofen or naproxen with regard to cardiovascular safety.","summary":"24,081 patients randomised head to head for a mean of 20 months. The largest direct comparison between the three drugs on heart, gut and kidney outcomes.","claim_ids":[],"hash":"38863dfb0c55aa5748301da1f0476c683194b8731ce57ff32358b023a18e1854"},{"id":"s20","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/39412516/","title":"NSAIDs: what is the actual risk of chronic kidney disease? A systematic review and meta-analysis (Rom J Intern Med 2025, PMID 39412516)","quote":"Forty studies with a total of 1757118 participants were included... The pooled odds ratio was 1.24 (95% CI: 1.11-1.39), and the pooled hazard ratio was 1.50 (95% CI: 1.31-1.7). The pooled hazard ratio (HR) for individuals with no CKD at baseline was 1.31, while for those with preexisting CKD, the HR was significantly higher at 1.67.","summary":"40 studies, 1.76 million participants. Long-term use raises the odds of developing or worsening chronic kidney disease, worst in those who already have it.","claim_ids":[],"hash":"97b6e1e1bfe27186b2f0ce082af49f0d05c6863ca0e810eb09d0a82fe0e50e53"},{"id":"s21","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/32297973/","title":"Non-steroidal anti-inflammatory drugs for acute low back pain (Cochrane 2020, PMID 32297973)","quote":"We included 32 trials, with a total of 5356 participants... There is moderate quality evidence that NSAIDs are slightly more effective in short-term (<= 3 weeks) reduction of pain intensity (visual analogue scale, 0 to 100) than placebo (mean difference (MD) -7.29 (95% CI -10.98 to -3.61); 4 RCTs, N = 815)... The magnitude of these effects is small and probably not clinically relevant.","summary":"32 trials, 5,356 participants. For acute back pain specifically, the drug beats placebo by 7.3 points on a 100-point scale, which the reviewers themselves call probably not clinically relevant.","claim_ids":[],"hash":"3172c5960a9de7b078f9bbfcfe5e7c7eb2e21c38386449af40d2c28a92b7fe28"},{"id":"s22","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/26863524/","title":"Non-steroidal anti-inflammatory drugs for chronic low back pain (Cochrane 2016, PMID 26863524)","quote":"There is low quality evidence that NSAIDs are more effective than placebo, with a mean difference in pain intensity score from baseline of -3.30 (95% CI -5.33 to -1.27) on a 0 to 100 visual analogue scale... When we only included RCTs at low risk of bias, differences in effect between NSAIDs and placebo were reduced.","summary":"13 trials. For chronic back pain the drug beats placebo by 3.3 points on a 100-point scale, and the effect shrinks further in the least-biased trials.","claim_ids":[],"hash":"3b5ef68bd7f2ae328a260c7c3a9d25207794dc88a074696e09b183220dd5c2ba"},{"id":"s23","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/26414123/","title":"Single dose oral analgesics for acute postoperative pain in adults — an overview of Cochrane reviews (Cochrane 2015, PMID 26414123)","quote":"The overview included 39 separate Cochrane Reviews with 41 analyses of single dose oral analgesics tested in acute postsurgical conditions, with results from about 50,000 participants in approximately 460 individual studies... Good (low) NNTs were obtained with ibuprofen 200 mg plus paracetamol 500 mg (NNT compared with placebo 1.6), ibuprofen fast acting 200 mg (2.1)... For comparison, ibuprofen acid 400 mg had an NNT of 2.5 (2.4 to 2.6).","summary":"39 Cochrane reviews, ~460 trials, ~50,000 participants. The scale of human evidence behind ibuprofen as a painkiller, and the exact number needed to treat.","claim_ids":[],"hash":"71e132983a555d776bdb3c516e6e8f4cfd007bd5465e1bd6fa0cd276739f4aa8"},{"id":"s24","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/34580864/","title":"Exercise therapy for chronic low back pain (Cochrane 2021, PMID 34580864)","quote":"We found moderate-certainty evidence that exercise treatment is more effective for treatment of chronic low back pain compared to no treatment, usual care or placebo comparisons for pain outcomes at earliest follow-up (MD -15.2, 95% CI -18.3 to -12.2), a clinically important difference.","summary":"249 randomised trials. The comparator that matters: exercise produces roughly double the acute-back-pain effect of the drug and five times its chronic-back-pain effect.","claim_ids":[],"hash":"741e6e2fc3ec90276815f92e27ea8a0ae3473e8c5e58cd71ef64dcd07f2e19b8"},{"id":"s25","type":"x","url":"https://x.com/rjust1421/status/2079732817420816700","title":"Six ibuprofen a day for years, kidney filtration flagged on bloodwork (anecdotal)","quote":"I took 6 ibuprofen daily for years until I retired. Don't need them anymore but last bloodwork showed filtration issues.","summary":"Anecdotal, single account. Reported kidney harm after years of high daily dosing.","claim_ids":[],"hash":"ec2b29b64a9cd26f7f0b95649cfec200110103d414c84f6002971e14429285e8"},{"id":"s26","type":"x","url":"https://x.com/TheFengHunter/status/2065052345642205232","title":"A stomach bleed that lasted a year, then twelve years avoiding the whole drug class (anecdotal)","quote":"Indomethacin gave me a stomach bleed that lasted a year bc of polypharmacy. I am currently taking a short course of naproxen bc of shoulder trauma from a sleep-related movement disorder. This is the first time in 12 years I have taken an NSAID. I begged for one. A little worried.","summary":"Anecdotal, single account. Reported gastrointestinal bleed, and the long shadow it casts on later treatment decisions.","claim_ids":[],"hash":"f66d8c7e9ddecb13930411a1e989345ad0ffc300fede2f640411fb7da154eb84"},{"id":"s27","type":"x","url":"https://x.com/jbf789/status/2060150691117605310","title":"Five ibuprofen a day for five years for back pain, stomach no longer tolerates it (anecdotal)","quote":"I took 5 Ibuprofen a day for 5 years...for back pain. Now I it hurts my stomach terribly! I can't tolerate it, at all.","summary":"Anecdotal, single account. Reported gastrointestinal harm; the exposure is exactly the long-term back-pain use pattern this page argues against.","claim_ids":[],"hash":"b86e601ff02f71536101e0c9cb204b0e2f9537791b156987eb807f4def95f549"},{"id":"s28","type":"x","url":"https://x.com/DadStrayer/status/2051426299843870966","title":"Ulcer, black stool, emergency room (anecdotal)","quote":"Be careful with the ibuprofen. I started taking so much that it caused an ulcer in my stomach and I ended up in an emergency room due to have black stool.","summary":"Anecdotal, single account. Reported gastrointestinal bleed requiring emergency care.","claim_ids":[],"hash":"4d899ceb63eafed2294f19817a41fe6d58d30a81f8aea6a88189f236ab07ef92"},{"id":"s29","type":"x","url":"https://x.com/BraisbyI/status/2076624300556112226","title":"Two years of naproxen for spinal pain, then a six-month cap (anecdotal)","quote":"I took Naproxen for almost 2 years to help with spinal pain, and as you say, I also had to take omeprazole. When I moved house recently my new Dr. told me that I was only allowed Naproxen for a 6 month period or it could do irrepealable damage?","summary":"Anecdotal, single account. No harm reported yet; included because it shows how differently two clinicians can treat the same duration question.","claim_ids":[],"hash":"085de0a7d0b4cf3e378b63c1d9236d4ee0d8b85401870af970b0962c0bfdd4a1"},{"id":"s30","type":"x","url":"https://x.com/meetjeo/status/2036117578112766127","title":"Over ten years of use, no reported problems (anecdotal)","quote":"I've been taking ibuprofen well over 10 years, even for long controlled periods of time. It's not going to cause any issues unless it's misused.","summary":"Anecdotal, single account. The negative-for-harm case, included because the panel would be dishonest without it — though the harm tables show the risk is real even when an individual escapes it.","claim_ids":[],"hash":"f763577c8299ee0159f56eabb839aa26f706a81f3793262aff27b423bbd8ec35"},{"id":"s31","type":"x","url":"https://x.com/BamaDarling/status/2080126143349346337","title":"Years of heavy use, kidney and liver tests pending (anecdotal)","quote":"I've been taking so much ibuprofen for Years, I'm getting my kidney & liver functions tested as well!","summary":"Anecdotal, single account. Outcome not yet known.","claim_ids":[],"hash":"ef5883d64eaba9dcce96228476c13b49682596eb443f3cb5fba8804406a9c343"},{"id":"s32","type":"x","url":"https://x.com/MuroCrypto/status/2083184469956059529","title":"A dried-out lower disc plus a year-old biceps tendon problem, six weeks of BPC-157 and TB-500 (anecdotal)","quote":"My lowest disc in the lower back is dried out, almost no fluid left, classic herniated disc. Flared up hard in March, could barely sit or stand without pain. Went on for 3 months with zero improvement. Also had a biceps tendon issue for over a year, couldn't curl on the right side. Plus something in the right shoulder that made shoulder press painful. In June I ran BPC-157 and TB-500 for about 6 weeks. Separate, normal doses like everyone recommends, injected into belly fat. After 3-4 weeks it already felt better. Now after the cycle, zero pain in biceps and shoulder. Disc still needs physio and rest, but already much better. I can clearly say these peptides helped me a lot. Don't know if it works the same for everyone, I'm no expert.","summary":"Anecdotal, single account, self-reported. Tendon and shoulder resolved; disc improved but explicitly not resolved. No control, no imaging.","claim_ids":[],"hash":"47d7b712d9a9a3abc12d931edae4a1f0611d6b8b9889eade76644a27c9b4ec5a"},{"id":"s33","type":"x","url":"https://x.com/Compound_Cowboi/status/2083353093878448335","title":"Elbow tendon pain of months, 2 mg injected locally each day (anecdotal)","quote":"Elbow tendinitis has been killing me for months. Started messing with my lifts and I was getting real tired of it. Been hitting it with 2mg BPC-157 every day, straight into the spot. A few weeks in and it's night and day. Pain is pretty much gone and I'm training normal again. Still got a little ways to go but damn it feels good to not have that constant ache.","summary":"Anecdotal, single account, self-reported. Reported benefit at a dose far above the commonly cited range, injected at the site.","claim_ids":[],"hash":"2161e6bf4304585552f866165329db66c846381f25207c7c133e73584f3686c1"},{"id":"s34","type":"x","url":"https://x.com/raymondAjenkins/status/2084117597361189075","title":"A two-and-a-half-year knee injury the poster says nothing else fixed (anecdotal)","quote":"Hgh, reta, bpc-157. Bpc helped fix a 2.5 year knee injury surgeons, Drs, and PT could not.","summary":"Anecdotal, single account, self-reported. Note the poster was taking two other compounds at the same time, so the effect cannot be attributed.","claim_ids":[],"hash":"0ea12b244b8336f3dccded1f25c24746aabe5d33b7a6248eef5b05ad9b0c6373"},{"id":"s35","type":"x","url":"https://x.com/BenWolf1425771/status/2083968934064316770","title":"Lifelong shoulder and joint pain on the BPC-157 plus TB-500 combination — post links a supplier (anecdotal)","quote":"Promise you peptides are No Joke, I used the wolverine stack (BPC-157 and TB-500) to alleviate lifelong shoulder and joint pains, Im sure it has other good health benefits. I found this peptide community on discord, the supplier on there is very reliable","summary":"Anecdotal, single account. Filed with an explicit conflict flag: the post advertises a supplier, which is a reason to discount it rather than exclude it.","claim_ids":[],"hash":"2c2e882cb8b43d6b55d4f7192225c8c25724de00f5ac0b64b5ce8da73e8e937d"},{"id":"s36","type":"x","url":"https://x.com/michaelo_x/status/2072480753938751554","title":"Rotator cuff surgery recommended, two eight-week cycles, surgery avoided — post ends in a follow-me pitch (anecdotal)","quote":"Surgeon told me I needed rotator cuff surgery. A few months later I was back to heavy lifting and never went under the knife... For my shoulder, I ran 500mcg every night, injected subq right into the fat around the injury site. I did an 8 week cycle, took a 2 week break, then ran it a second time. By the end of that second cycle I was already back under heavy weight and surgery wasn't on the table anymore... As far as side effects, I haven't had any. The only things I've heard from others are slight anhedonia at very high doses and some redness around the injection site.","summary":"Anecdotal, single account. Filed with an explicit conflict flag: the post is promotional and ends by soliciting followers. Also the clearest statement of a commonly used dose and cycle.","claim_ids":[],"hash":"a3a2b9f49b785f5b9aede092727408201e0504442142f18b589d4331234a15bd"},{"id":"s37","type":"x","url":"https://x.com/Shift_leader06/status/2071665450971181146","title":"Two months, rotator cuff quiet during training, heartburn gone (anecdotal)","quote":"Took bpc-157 for two months, heartburn basically gone unless I eat chili or something like that right before bed. Rotator cuff injury from jujitsu not bothering me when I lift or roll. Mood stable… like if something happens that would make me mad I let slide","summary":"Anecdotal, single account. The reported heartburn change is the only place in this panel that lines up with the animal gut-protection data.","claim_ids":[],"hash":"0cbb7228485ed9620dfc5fabcbf620edb3e5abc6d1b9ef075d56b1e8e8757b6c"},{"id":"s38","type":"x","url":"https://x.com/AJA_Cortes/status/1794522474702336108","title":"A disc flare that resolved in seven days, with placebo raised by the user himself (anecdotal)","quote":"Had a bad disc flare up this past weekend (I had a disc herniation at L5-S1 many years ago, never been the same since) Was staggering around in pain for a day and a half. Decided to try to taking oral BPC157 at 2000mcg daily -Also got two deep tissue massages, and a chiro adjustment. 7 days later, pain free. Did the BPC157 help? Maybe, maybe not. Im always open to possibility of placebo. Regardless, it was a fast recovery","summary":"Anecdotal, single account, and the most intellectually honest one in the set: three interventions at once, a seven-day window in which a flare commonly settles anyway, and the user naming placebo himself.","claim_ids":[],"hash":"8f0eb38d95582b643040a4fb115e3748f2cee99c7ab079004ffd3cef2e2ca6b3"},{"id":"s39","type":"x","url":"https://x.com/LtCrandog/status/2082758463407473109","title":"Ten years of on-and-off use and a flat negative verdict (anecdotal)","quote":"Appreciate you acknowledging the potential placebo benefits. Been taking bpc157 off and on for over 10 years and really don't think it does much. Apart from not really healing anything I've had random tendinitis pop up even while being on bpc","summary":"Anecdotal, single account. Reported no benefit over the longest exposure in this panel, and new tendon pain appearing during use.","claim_ids":[],"hash":"b711610bd7452de29dff9ec054c71e643a51304fba971babe3284b64eb6e41bf"},{"id":"s40","type":"x","url":"https://x.com/WayneLMarsh/status/2081368522601509373","title":"Eight weeks for a shoulder, judged not a success — but stomach problems returned after stopping (anecdotal)","quote":"I took BPC-157 for a shoulder injury. After 8 weeks the pain had lessened but I really didn't class it as a success. Came off and about 2 weeks later had problems with my stomach that had disappeared out of my awareness whilst taking BPC. Evaluating on a systemic level has better chance of catching this kind of thing. Sometimes the focus is too narrow.","summary":"Anecdotal, single account. Negative for the injury claim and incidentally supportive of the gut-protection claim — the two things are separable and this account separates them.","claim_ids":[],"hash":"a80d221defb949278f7f543dfb562ebefc3c6b4ce604a995d1f2b77dafd8ce28"},{"id":"s41","type":"x","url":"https://x.com/FreezerBurnv2/status/2080030523506806963","title":"An injection-site problem from using too large a needle (anecdotal)","quote":"I just transferred my BPC-157 to a pen and I think I got too big of a needle (Novofine 8mm/30g Needles) for the tip so good brand but wrong size I think, but when I used it some blood went back into the cart after injection... also just now healing from the injection points.","summary":"Anecdotal, single account. No injury outcome reported. The only physical complaint anywhere in this panel, and it is about the needle rather than the compound.","claim_ids":[],"hash":"4e8ede2bf557ffde3425fb13e1dfe65dca0331a96e99148e2b176100aba466c4"},{"id":"s42","type":"regulatory","url":"https://api.fda.gov/drug/event.json?search=patient.drug.openfda.generic_name:%22ibuprofen%22&count=patient.reaction.reactionmeddrapt.exact","title":"openFDA adverse event reports naming ibuprofen and naproxen (FAERS, queried 2026-08-04)","quote":"283,544 total reports name ibuprofen and 165,063 name naproxen. Most frequent reported terms for ibuprofen: DRUG INEFFECTIVE 27,383; PAIN 19,490; FATIGUE 18,754; NAUSEA 18,293. Serious event counts for ibuprofen / naproxen: acute kidney injury 7,141 / 3,145; renal failure 4,216 / 2,562; gastrointestinal haemorrhage 2,689 / 1,486; myocardial infarction 1,781 / 1,770; gastric ulcer 1,394 / 867; melaena 1,208 / 478; cardiac failure 634 / 305; gastric haemorrhage 622 / 489; duodenal ulcer 614 / 359. FAERS reports are voluntary and uncontrolled; they carry no denominator and cannot produce an incidence rate.","claim_ids":[],"hash":"ee2b10ba8a567e29f96bc0ee57f1dbaa8a371421e0b0ee8ef9f8dcf2147a97e8"}],"anecdotal_sources":[{"id":"s25","type":"x","url":"https://x.com/rjust1421/status/2079732817420816700","title":"Six ibuprofen a day for years, kidney filtration flagged on bloodwork (anecdotal)","quote":"I took 6 ibuprofen daily for years until I retired. Don't need them anymore but last bloodwork showed filtration issues.","summary":"Anecdotal, single account. Reported kidney harm after years of high daily dosing.","claim_ids":[],"hash":"ec2b29b64a9cd26f7f0b95649cfec200110103d414c84f6002971e14429285e8"},{"id":"s26","type":"x","url":"https://x.com/TheFengHunter/status/2065052345642205232","title":"A stomach bleed that lasted a year, then twelve years avoiding the whole drug class (anecdotal)","quote":"Indomethacin gave me a stomach bleed that lasted a year bc of polypharmacy. I am currently taking a short course of naproxen bc of shoulder trauma from a sleep-related movement disorder. This is the first time in 12 years I have taken an NSAID. I begged for one. A little worried.","summary":"Anecdotal, single account. Reported gastrointestinal bleed, and the long shadow it casts on later treatment decisions.","claim_ids":[],"hash":"f66d8c7e9ddecb13930411a1e989345ad0ffc300fede2f640411fb7da154eb84"},{"id":"s27","type":"x","url":"https://x.com/jbf789/status/2060150691117605310","title":"Five ibuprofen a day for five years for back pain, stomach no longer tolerates it (anecdotal)","quote":"I took 5 Ibuprofen a day for 5 years...for back pain. Now I it hurts my stomach terribly! I can't tolerate it, at all.","summary":"Anecdotal, single account. Reported gastrointestinal harm; the exposure is exactly the long-term back-pain use pattern this page argues against.","claim_ids":[],"hash":"b86e601ff02f71536101e0c9cb204b0e2f9537791b156987eb807f4def95f549"},{"id":"s28","type":"x","url":"https://x.com/DadStrayer/status/2051426299843870966","title":"Ulcer, black stool, emergency room (anecdotal)","quote":"Be careful with the ibuprofen. I started taking so much that it caused an ulcer in my stomach and I ended up in an emergency room due to have black stool.","summary":"Anecdotal, single account. Reported gastrointestinal bleed requiring emergency care.","claim_ids":[],"hash":"4d899ceb63eafed2294f19817a41fe6d58d30a81f8aea6a88189f236ab07ef92"},{"id":"s29","type":"x","url":"https://x.com/BraisbyI/status/2076624300556112226","title":"Two years of naproxen for spinal pain, then a six-month cap (anecdotal)","quote":"I took Naproxen for almost 2 years to help with spinal pain, and as you say, I also had to take omeprazole. When I moved house recently my new Dr. told me that I was only allowed Naproxen for a 6 month period or it could do irrepealable damage?","summary":"Anecdotal, single account. No harm reported yet; included because it shows how differently two clinicians can treat the same duration question.","claim_ids":[],"hash":"085de0a7d0b4cf3e378b63c1d9236d4ee0d8b85401870af970b0962c0bfdd4a1"},{"id":"s30","type":"x","url":"https://x.com/meetjeo/status/2036117578112766127","title":"Over ten years of use, no reported problems (anecdotal)","quote":"I've been taking ibuprofen well over 10 years, even for long controlled periods of time. It's not going to cause any issues unless it's misused.","summary":"Anecdotal, single account. The negative-for-harm case, included because the panel would be dishonest without it — though the harm tables show the risk is real even when an individual escapes it.","claim_ids":[],"hash":"f763577c8299ee0159f56eabb839aa26f706a81f3793262aff27b423bbd8ec35"},{"id":"s31","type":"x","url":"https://x.com/BamaDarling/status/2080126143349346337","title":"Years of heavy use, kidney and liver tests pending (anecdotal)","quote":"I've been taking so much ibuprofen for Years, I'm getting my kidney & liver functions tested as well!","summary":"Anecdotal, single account. Outcome not yet known.","claim_ids":[],"hash":"ef5883d64eaba9dcce96228476c13b49682596eb443f3cb5fba8804406a9c343"},{"id":"s32","type":"x","url":"https://x.com/MuroCrypto/status/2083184469956059529","title":"A dried-out lower disc plus a year-old biceps tendon problem, six weeks of BPC-157 and TB-500 (anecdotal)","quote":"My lowest disc in the lower back is dried out, almost no fluid left, classic herniated disc. Flared up hard in March, could barely sit or stand without pain. Went on for 3 months with zero improvement. Also had a biceps tendon issue for over a year, couldn't curl on the right side. Plus something in the right shoulder that made shoulder press painful. In June I ran BPC-157 and TB-500 for about 6 weeks. Separate, normal doses like everyone recommends, injected into belly fat. After 3-4 weeks it already felt better. Now after the cycle, zero pain in biceps and shoulder. Disc still needs physio and rest, but already much better. I can clearly say these peptides helped me a lot. Don't know if it works the same for everyone, I'm no expert.","summary":"Anecdotal, single account, self-reported. Tendon and shoulder resolved; disc improved but explicitly not resolved. No control, no imaging.","claim_ids":[],"hash":"47d7b712d9a9a3abc12d931edae4a1f0611d6b8b9889eade76644a27c9b4ec5a"},{"id":"s33","type":"x","url":"https://x.com/Compound_Cowboi/status/2083353093878448335","title":"Elbow tendon pain of months, 2 mg injected locally each day (anecdotal)","quote":"Elbow tendinitis has been killing me for months. Started messing with my lifts and I was getting real tired of it. Been hitting it with 2mg BPC-157 every day, straight into the spot. A few weeks in and it's night and day. Pain is pretty much gone and I'm training normal again. Still got a little ways to go but damn it feels good to not have that constant ache.","summary":"Anecdotal, single account, self-reported. Reported benefit at a dose far above the commonly cited range, injected at the site.","claim_ids":[],"hash":"2161e6bf4304585552f866165329db66c846381f25207c7c133e73584f3686c1"},{"id":"s34","type":"x","url":"https://x.com/raymondAjenkins/status/2084117597361189075","title":"A two-and-a-half-year knee injury the poster says nothing else fixed (anecdotal)","quote":"Hgh, reta, bpc-157. Bpc helped fix a 2.5 year knee injury surgeons, Drs, and PT could not.","summary":"Anecdotal, single account, self-reported. Note the poster was taking two other compounds at the same time, so the effect cannot be attributed.","claim_ids":[],"hash":"0ea12b244b8336f3dccded1f25c24746aabe5d33b7a6248eef5b05ad9b0c6373"},{"id":"s35","type":"x","url":"https://x.com/BenWolf1425771/status/2083968934064316770","title":"Lifelong shoulder and joint pain on the BPC-157 plus TB-500 combination — post links a supplier (anecdotal)","quote":"Promise you peptides are No Joke, I used the wolverine stack (BPC-157 and TB-500) to alleviate lifelong shoulder and joint pains, Im sure it has other good health benefits. I found this peptide community on discord, the supplier on there is very reliable","summary":"Anecdotal, single account. Filed with an explicit conflict flag: the post advertises a supplier, which is a reason to discount it rather than exclude it.","claim_ids":[],"hash":"2c2e882cb8b43d6b55d4f7192225c8c25724de00f5ac0b64b5ce8da73e8e937d"},{"id":"s36","type":"x","url":"https://x.com/michaelo_x/status/2072480753938751554","title":"Rotator cuff surgery recommended, two eight-week cycles, surgery avoided — post ends in a follow-me pitch (anecdotal)","quote":"Surgeon told me I needed rotator cuff surgery. A few months later I was back to heavy lifting and never went under the knife... For my shoulder, I ran 500mcg every night, injected subq right into the fat around the injury site. I did an 8 week cycle, took a 2 week break, then ran it a second time. By the end of that second cycle I was already back under heavy weight and surgery wasn't on the table anymore... As far as side effects, I haven't had any. The only things I've heard from others are slight anhedonia at very high doses and some redness around the injection site.","summary":"Anecdotal, single account. Filed with an explicit conflict flag: the post is promotional and ends by soliciting followers. Also the clearest statement of a commonly used dose and cycle.","claim_ids":[],"hash":"a3a2b9f49b785f5b9aede092727408201e0504442142f18b589d4331234a15bd"},{"id":"s37","type":"x","url":"https://x.com/Shift_leader06/status/2071665450971181146","title":"Two months, rotator cuff quiet during training, heartburn gone (anecdotal)","quote":"Took bpc-157 for two months, heartburn basically gone unless I eat chili or something like that right before bed. Rotator cuff injury from jujitsu not bothering me when I lift or roll. Mood stable… like if something happens that would make me mad I let slide","summary":"Anecdotal, single account. The reported heartburn change is the only place in this panel that lines up with the animal gut-protection data.","claim_ids":[],"hash":"0cbb7228485ed9620dfc5fabcbf620edb3e5abc6d1b9ef075d56b1e8e8757b6c"},{"id":"s38","type":"x","url":"https://x.com/AJA_Cortes/status/1794522474702336108","title":"A disc flare that resolved in seven days, with placebo raised by the user himself (anecdotal)","quote":"Had a bad disc flare up this past weekend (I had a disc herniation at L5-S1 many years ago, never been the same since) Was staggering around in pain for a day and a half. Decided to try to taking oral BPC157 at 2000mcg daily -Also got two deep tissue massages, and a chiro adjustment. 7 days later, pain free. Did the BPC157 help? Maybe, maybe not. Im always open to possibility of placebo. Regardless, it was a fast recovery","summary":"Anecdotal, single account, and the most intellectually honest one in the set: three interventions at once, a seven-day window in which a flare commonly settles anyway, and the user naming placebo himself.","claim_ids":[],"hash":"8f0eb38d95582b643040a4fb115e3748f2cee99c7ab079004ffd3cef2e2ca6b3"},{"id":"s39","type":"x","url":"https://x.com/LtCrandog/status/2082758463407473109","title":"Ten years of on-and-off use and a flat negative verdict (anecdotal)","quote":"Appreciate you acknowledging the potential placebo benefits. Been taking bpc157 off and on for over 10 years and really don't think it does much. Apart from not really healing anything I've had random tendinitis pop up even while being on bpc","summary":"Anecdotal, single account. Reported no benefit over the longest exposure in this panel, and new tendon pain appearing during use.","claim_ids":[],"hash":"b711610bd7452de29dff9ec054c71e643a51304fba971babe3284b64eb6e41bf"},{"id":"s40","type":"x","url":"https://x.com/WayneLMarsh/status/2081368522601509373","title":"Eight weeks for a shoulder, judged not a success — but stomach problems returned after stopping (anecdotal)","quote":"I took BPC-157 for a shoulder injury. After 8 weeks the pain had lessened but I really didn't class it as a success. Came off and about 2 weeks later had problems with my stomach that had disappeared out of my awareness whilst taking BPC. Evaluating on a systemic level has better chance of catching this kind of thing. Sometimes the focus is too narrow.","summary":"Anecdotal, single account. Negative for the injury claim and incidentally supportive of the gut-protection claim — the two things are separable and this account separates them.","claim_ids":[],"hash":"a80d221defb949278f7f543dfb562ebefc3c6b4ce604a995d1f2b77dafd8ce28"},{"id":"s41","type":"x","url":"https://x.com/FreezerBurnv2/status/2080030523506806963","title":"An injection-site problem from using too large a needle (anecdotal)","quote":"I just transferred my BPC-157 to a pen and I think I got too big of a needle (Novofine 8mm/30g Needles) for the tip so good brand but wrong size I think, but when I used it some blood went back into the cart after injection... also just now healing from the injection points.","summary":"Anecdotal, single account. No injury outcome reported. The only physical complaint anywhere in this panel, and it is about the needle rather than the compound.","claim_ids":[],"hash":"4e8ede2bf557ffde3425fb13e1dfe65dca0331a96e99148e2b176100aba466c4"}],"scientific_sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/16210573/","title":"Indomethacin and celecoxib impair rotator cuff tendon-to-bone healing","quote":"There were significantly lower failure loads in the celecoxib and indomethacin groups compared with the control groups at 2, 4, and 8 weeks (P < .001)","claim_ids":["c1"],"hash":"10da630fc7b601f4e04d5c233d11a3a69bd00d235fa0298be3c7c44d81e0e287"},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3764618/","title":"NSAID therapy effects on healing of bone, tendon, and the enthesis","quote":"Numerous animal studies have demonstrated a consistent negative effect of NSAID treatment on endochondral ossification during fracture healing.","claim_ids":["c1","c2"],"hash":"6195401ea20a004f528db3a4648bc3e5bdaae4300692e115db96c363cd9ba55e"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/23982408/","title":"The detrimental effects of systemic Ibuprofen delivery on tendon healing are time-dependent","quote":"Early administration of ibuprofen in the postoperative period was detrimental to tendon healing, while delayed administration did not affect tendon healing.","claim_ids":["c1"],"hash":"74343a921af7d7ca56c561126b2a0b5c0b879216a1645d3002c337f7c5490f28"},{"id":"s4","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9454294/","title":"Cross-species comparisons reveal resistance of human skeletal stem cells to inhibition by NSAIDs","quote":"human SSCs (hSSC) downregulated COX2 expression during differentiation and showed impaired osteogenic capacity if COX2 was lentivirally overexpressed.","claim_ids":["c5"],"hash":"2ee1555d35e7e147f911fafc04b1cfcf10a2afece99ab0b68223c93e3bd0fb5a"},{"id":"s5","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11420001/","title":"Do NSAIDs affect bone healing rate, delay union, or cause non-union: an updated systematic review and meta-analysis","quote":"There was no significant difference in the rates of non-union or delayed union between NSAID users and non-users (pooled adjusted OR = 1.11; 95% CI: 0.99-1.23)","claim_ids":["c5"],"hash":"7df8e5ef9212a17f9ec542dd54184e732aba2ff78956e6382e4b5507ed9f1760"},{"id":"s6","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8268344/","title":"NSAIDs and bone healing in animal models - a systematic review and meta-analysis","quote":"NSAIDs administration decreased the biomechanical properties of healing bones after fracture surgery in comparison to the control group.","claim_ids":["c4"],"hash":"86964d7982aa69758288590a722827197fcfe6aa485c4a682cecb28cc7e6717b"},{"id":"s7","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/19713429/","title":"Local NSAID infusion inhibits satellite cell proliferation in human skeletal muscle after eccentric exercise","quote":"The number of Pax7(+) cells was unchanged in the leg muscles exposed to the NSAID (0.07 +/- 0.01).","claim_ids":["c3"],"hash":"aefb763b1c62b75f28cc439c6e8fcb7be27c6ec7ab39320d8e5e3e3af4230814"},{"id":"s8","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/19628768/","title":"Rescue of impaired fracture healing in COX-2-/- mice via activation of prostaglandin E2 receptor subtype 4","quote":"The EP4 agonist markedly improved the impaired healing in COX-2(-/-) mice ... a near complete reversal of bone formation","claim_ids":["c2","c8"],"hash":"d36bdc9fe8e9ef04d333908313d8468a860c31628d3b1f89311c599df771ff44"},{"id":"s9","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3276605/","title":"Reduced COX-2 Expression in Aged Mice Is Associated With Impaired Fracture Healing","quote":"Cyclooxygenase 2 (COX-2), the inducible regulator of prostaglandin E2 (PGE2) synthesis, is critical for normal bone repair.","claim_ids":["c2"],"hash":"23bb5491d06eb0cf4c86d4a2b520003cf834f3efa837c3bb6b5e43832cca3df8"},{"id":"s10","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/14554208/","title":"Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and stimulates tendocyte growth in vitro","quote":"pentadecapeptide BPC 157 fully improves recovery: (i) biomechanically, increased load of failure, load of failure per area and Young's modulus of elasticity","claim_ids":["c7"],"hash":"51af90a8551727df67ac6f100b86c4ec290e6c9a147572f62d9c2d6a878bf448"},{"id":"s11","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/21030672/","title":"The promoting effect of BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration","quote":"BPC 157 promotes the ex vivo outgrowth of tendon fibroblasts from tendon explants, cell survival under stress, and the in vitro migration","claim_ids":["c7"],"hash":"f5a5a3fa3b4a384fdb185c63f9cc02f2a01d82af3f771b4f4111acee69109587"},{"id":"s12","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/20388964/","title":"Modulatory effect of BPC 157 on angiogenesis in muscle and tendon healing","quote":"BPC 157 stimulating angiogenesis by up-regulating VEGF expression.","claim_ids":["c8"],"hash":"1e821859ff8033f26ee51fba6a6e95a63cd8e6a6b64becf4bd6d64cee299bed2"},{"id":"s13","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/21295044/","title":"BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced GI, liver, and encephalopathy lesions","quote":"may encourage its further use as a therapy to counteract diclofenac- and other NSAID-induced toxicity.","claim_ids":["c9"],"hash":"5fbbe156c48418182f0dca535b2675e495b4b0b806ff14284bacb3e216e8c615"},{"id":"s14","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/9403784/","title":"BPC 157 positively affects both NSAID-induced gastrointestinal lesions and adjuvant arthritis in rats","quote":"Given with the investigated NSAIAs, BPC 157 consistently reduced the otherwise prominent lesions in the stomach ... as well as the lesions in the small intestine","claim_ids":["c9"],"hash":"6fb170120e1fc87c2916ae58eef04c02d037ae582d8fb041776a1ee80bc556b5"},{"id":"s15","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12746519/","title":"NSAIDs and Risk of Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis","quote":"ketorolac showed the highest risk (OR 20.67, 95% CI: 14.56-29.34)","claim_ids":["c6"],"hash":"6fca5f2bbe021a787908a14f4ef6d0cf07bdada5db95b0a3c7ba941bb95f5fe8"},{"id":"s16","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/32805126/","title":"Management of Acute Pain From Non-Low Back Musculoskeletal Injuries: ACP/AAFP Clinical Guideline","quote":"clinicians treat patients with acute pain from non-low back, musculoskeletal injuries with topical nonsteroidal anti-inflammatory drugs (NSAIDs) ... as first-line therapy","claim_ids":["c10"],"hash":"e5642db09702f30980489b03f51dcd5b255fa521872e075ccc96fc9b2e5fa607"},{"id":"s17","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12890389/","title":"Lumbar Disc Herniation Resorption: When and How Does It Occur?","quote":"controlled inflammatory responses are necessary for disc resorption ... standard anti-inflammatory treatments may paradoxically impede this process.","claim_ids":[],"hash":"378dbfe65853810dd9873a4585304fbc9dd591b7a22b93550450126156150232"},{"id":"s18","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/23726390/","title":"Vascular and upper gastrointestinal effects of NSAIDs: meta-analyses of individual participant data from randomised trials (Lancet 2013, PMID 23726390)","quote":"Major vascular events were increased by about a third by a coxib (rate ratio [RR] 1.37) or diclofenac (1.41)... Ibuprofen also significantly increased major coronary events (2.22), but not major vascular events (1.44). Naproxen did not significantly increase major vascular events (0.93)... Heart failure risk was roughly doubled by all NSAIDs. All NSAID regimens increased upper gastrointestinal complications (coxibs 1.81; diclofenac 1.89; ibuprofen 3.97; and naproxen 4.22).","summary":"280 placebo-controlled trials (124,513 participants) plus 474 head-to-head trials (229,296). The definitive per-drug harm table for heart, heart failure and upper gut.","claim_ids":[],"hash":"0bd5346b10c72b3118276aa39003dbc0293e6548e28d52e1e824a030d4e6a0ce"},{"id":"s19","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/27959716/","title":"Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis — PRECISION (NEJM 2016, PMID 27959716)","quote":"A total of 24,081 patients were randomly assigned to the celecoxib group... the naproxen group... or the ibuprofen group for a mean treatment duration of 20.3 months... The risk of gastrointestinal events was significantly lower with celecoxib than with naproxen (P=0.01) or ibuprofen (P=0.002); the risk of renal events was significantly lower with celecoxib than with ibuprofen (P=0.004)... At moderate doses, celecoxib was found to be noninferior to ibuprofen or naproxen with regard to cardiovascular safety.","summary":"24,081 patients randomised head to head for a mean of 20 months. The largest direct comparison between the three drugs on heart, gut and kidney outcomes.","claim_ids":[],"hash":"38863dfb0c55aa5748301da1f0476c683194b8731ce57ff32358b023a18e1854"},{"id":"s20","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/39412516/","title":"NSAIDs: what is the actual risk of chronic kidney disease? A systematic review and meta-analysis (Rom J Intern Med 2025, PMID 39412516)","quote":"Forty studies with a total of 1757118 participants were included... The pooled odds ratio was 1.24 (95% CI: 1.11-1.39), and the pooled hazard ratio was 1.50 (95% CI: 1.31-1.7). The pooled hazard ratio (HR) for individuals with no CKD at baseline was 1.31, while for those with preexisting CKD, the HR was significantly higher at 1.67.","summary":"40 studies, 1.76 million participants. Long-term use raises the odds of developing or worsening chronic kidney disease, worst in those who already have it.","claim_ids":[],"hash":"97b6e1e1bfe27186b2f0ce082af49f0d05c6863ca0e810eb09d0a82fe0e50e53"},{"id":"s21","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/32297973/","title":"Non-steroidal anti-inflammatory drugs for acute low back pain (Cochrane 2020, PMID 32297973)","quote":"We included 32 trials, with a total of 5356 participants... There is moderate quality evidence that NSAIDs are slightly more effective in short-term (<= 3 weeks) reduction of pain intensity (visual analogue scale, 0 to 100) than placebo (mean difference (MD) -7.29 (95% CI -10.98 to -3.61); 4 RCTs, N = 815)... The magnitude of these effects is small and probably not clinically relevant.","summary":"32 trials, 5,356 participants. For acute back pain specifically, the drug beats placebo by 7.3 points on a 100-point scale, which the reviewers themselves call probably not clinically relevant.","claim_ids":[],"hash":"3172c5960a9de7b078f9bbfcfe5e7c7eb2e21c38386449af40d2c28a92b7fe28"},{"id":"s22","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/26863524/","title":"Non-steroidal anti-inflammatory drugs for chronic low back pain (Cochrane 2016, PMID 26863524)","quote":"There is low quality evidence that NSAIDs are more effective than placebo, with a mean difference in pain intensity score from baseline of -3.30 (95% CI -5.33 to -1.27) on a 0 to 100 visual analogue scale... When we only included RCTs at low risk of bias, differences in effect between NSAIDs and placebo were reduced.","summary":"13 trials. For chronic back pain the drug beats placebo by 3.3 points on a 100-point scale, and the effect shrinks further in the least-biased trials.","claim_ids":[],"hash":"3b5ef68bd7f2ae328a260c7c3a9d25207794dc88a074696e09b183220dd5c2ba"},{"id":"s23","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/26414123/","title":"Single dose oral analgesics for acute postoperative pain in adults — an overview of Cochrane reviews (Cochrane 2015, PMID 26414123)","quote":"The overview included 39 separate Cochrane Reviews with 41 analyses of single dose oral analgesics tested in acute postsurgical conditions, with results from about 50,000 participants in approximately 460 individual studies... Good (low) NNTs were obtained with ibuprofen 200 mg plus paracetamol 500 mg (NNT compared with placebo 1.6), ibuprofen fast acting 200 mg (2.1)... For comparison, ibuprofen acid 400 mg had an NNT of 2.5 (2.4 to 2.6).","summary":"39 Cochrane reviews, ~460 trials, ~50,000 participants. The scale of human evidence behind ibuprofen as a painkiller, and the exact number needed to treat.","claim_ids":[],"hash":"71e132983a555d776bdb3c516e6e8f4cfd007bd5465e1bd6fa0cd276739f4aa8"},{"id":"s24","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/34580864/","title":"Exercise therapy for chronic low back pain (Cochrane 2021, PMID 34580864)","quote":"We found moderate-certainty evidence that exercise treatment is more effective for treatment of chronic low back pain compared to no treatment, usual care or placebo comparisons for pain outcomes at earliest follow-up (MD -15.2, 95% CI -18.3 to -12.2), a clinically important difference.","summary":"249 randomised trials. The comparator that matters: exercise produces roughly double the acute-back-pain effect of the drug and five times its chronic-back-pain effect.","claim_ids":[],"hash":"741e6e2fc3ec90276815f92e27ea8a0ae3473e8c5e58cd71ef64dcd07f2e19b8"}],"user_reports":[],"related_articles":[{"slug":"bpc-157","title":"BPC-157: Body Protection Compound","claims":[{"id":"c1","text":"BPC-157 is a made-in-a-lab chain of 15 amino acids, copied from a stretch of a protein found in stomach juice.","tier":"human"},{"id":"c2","text":"More than 100 studies in animals and in cells report faster healing — better-organised collagen, and blood vessels growing into the wound — across tendon, gut, muscle, bone and nerve.","tier":"preclinical"},{"id":"c3","text":"A 2025 pilot study dripped up to 20 mg of BPC-157 into the veins of two healthy adults. Nothing went wrong with their vital signs, their blood tests, or how they said they felt.","tier":"human"},{"id":"c4","text":"The proposed explanation is that BPC-157 encourages new blood vessel growth at the injury and works on the body’s nitric oxide system. That is a proposal drawn from animal work, not something measured in a person.","tier":"mechanistic"},{"id":"c6","text":"One person reported feeling sick within two weeks of starting BPC-157 and stopped taking it. That is one person. The same account was then ingested 25 more times from other copies of the same thread, and each copy is listed below so the count is visible rather than hidden.","tier":"anecdotal"},{"id":"c8","text":"The second copy of that same single nausea report, ingested again from another copy of the same thread. It is the same one person, not 2 people.","tier":"anecdotal"},{"id":"c10","text":"The third copy of that same single nausea report, ingested again from another copy of the same thread. It is the same one person, not 3 people.","tier":"anecdotal"},{"id":"c11","text":"Ten of the sources catalogued on this page are vendors and clinics selling BPC-157. That is marketing material, and it is listed here as marketing material rather than as evidence.","tier":"human"}]},{"slug":"tb-500","title":"TB-500: a seven-amino-acid fragment sold under the name of the protein thymosin beta-4","claims":[{"id":"c1","text":"TB-500 is sold as a made-in-a-lab version of thymosin beta-4, a small protein your own cells already make.","tier":"mechanistic"},{"id":"c300","text":"Thymosin beta-4 is the body's main handler of loose actin, the building material a cell uses to change shape and crawl.","tier":"mechanistic"},{"id":"c301","text":"Holding that building material is how thymosin beta-4 sets the pace at which cells move into an injury, and cells moving into an injury is what repair is.","tier":"mechanistic"},{"id":"c2","text":"The same seven amino acids that let thymosin beta-4 grip actin also make new blood vessels grow.","tier":"mechanistic"},{"id":"c302","text":"Those seven amino acids also make the cells that line blood vessels crawl, so new blood vessel growth is not a side effect of the repair. It is part of it.","tier":"mechanistic"},{"id":"c3","text":"In controlled animal wound experiments, thymosin beta-4 made skin grow back across the wound 42 to 61% faster than in untreated animals.","tier":"preclinical"},{"id":"c303","text":"Those same animal wounds laid down more collagen and grew more new blood vessels.","tier":"preclinical"},{"id":"c4","text":"Thymosin beta-4, the full protein rather than the fragment in the vial, was tested in people with pressure sores and long-standing leg ulcers in proper randomised, double-blind, placebo-controlled trials.","tier":"human"}]},{"slug":"ara-290","title":"ARA-290 (cibinetide): a fragment of erythropoietin that acts on nerves, not on blood","claims":[{"id":"c1","text":"ARA-290 (cibinetide) is an 11-amino-acid peptide from EPO's helix-B surface that activates the innate repair receptor (EPOR/beta-common heterocomplex) to drive tissue repair, distinct from EPO's erythropoietic receptor.","tier":"mechanistic"},{"id":"c2","text":"Because it engages the innate repair receptor rather than the homodimeric EPO receptor, ARA-290 does not stimulate erythropoiesis or raise hematocrit, avoiding EPO's thrombotic risk.","tier":"mechanistic"},{"id":"c3","text":"The mechanism was defined by Michael Brines and Anthony Cerami, who showed EPO's tissue protection runs through an EPOR/beta-common-receptor heterocomplex.","tier":"mechanistic"},{"id":"c4","text":"In a randomized, double-blind, placebo-controlled pilot in sarcoidosis patients with small-fiber neuropathy, ARA 290 significantly improved neuropathy symptom scores versus placebo.","tier":"human"},{"id":"c5","text":"In a Phase 2b RCT (n=64), 4 mg/day cibinetide significantly increased corneal nerve fiber area and raised GAP-43+ regenerating intraepidermal nerve fibers, an objective structural sign of nerve regeneration.","tier":"human"},{"id":"c6","text":"In type 2 diabetics, ARA 290 improved neuropathic symptoms alongside HbA1c and lipids over 56 days without safety issues.","tier":"human"},{"id":"c7","text":"In nerve-injury models, ARA 290 produced long-lasting, dose-dependent reductions in allodynia coupled to suppression of the spinal microglial neuroinflammatory response.","tier":"preclinical"},{"id":"c8","text":"ARA 290 inhibits macrophage activation and pro-inflammatory cytokine release (IL-6, IL-12, TNF-alpha) and protects cells from cytokine-induced apoptosis.","tier":"preclinical"}]},{"slug":"herniated-disc","title":"Herniated disc: 70% resorb without surgery and 95% recover at one year","claims":[{"id":"c1","text":"A herniated disc is not a broken part. Tissue has moved, that is all: the soft centre of the disc has pushed out through a tear in the tough outer ring.","tier":"mechanistic"},{"id":"c300","text":"The tear almost always sits towards the back and a little to one side, where the tough outer ring is thinnest. A nerve root runs right there, which is why the escaped material ends up pressing on it.","tier":"mechanistic"},{"id":"c2","text":"Most herniated discs shrink away on their own. Pooled data put it at roughly two-thirds of the people who were never operated on.","tier":"human"},{"id":"c3","text":"The biggest herniations are the ones that clear best. A piece squeezed right out through a tear, or one that has broken clean away, disappears completely far more often than a small bulge that never breached the outer ring.","tier":"human"},{"id":"c4","text":"The fragment does not simply dry up and vanish. Scavenger cells from your immune system, called macrophages, move in on the escaped material and eat it.","tier":"mechanistic"},{"id":"c301","text":"Those same scavenger cells set off enzymes and new blood vessel growth, and between them the fragment is dissolved and carried away.","tier":"mechanistic"},{"id":"c5","text":"Mature disc tissue has almost no blood supply of its own, which is why it heals so slowly.","tier":"mechanistic"},{"id":"c302","text":"Recovery depends on new blood vessels growing in at the edge of the herniation, pushed along by a signalling protein called VEGF, bringing a blood supply to a place that normally has none.","tier":"mechanistic"}]},{"slug":"degenerative-disc-disease","title":"Degenerative Disc Disease","claims":[{"id":"c1","text":"Degeneration starts as a failure to hold water. The soft centre of the disc loses aggrecan, the molecule that pins water in place, and the water leaves with it.","tier":"mechanistic"},{"id":"c320","text":"A disc is roughly 90% water at birth and around 70% by age 60. Once it is that dry it can no longer hold pressure and share the load the way it is supposed to.","tier":"mechanistic"},{"id":"c2","text":"The disc heals badly because it is the largest structure in the body with no blood supply of its own. Everything it needs seeps slowly in through the bony plates above and below it.","tier":"mechanistic"},{"id":"c3","text":"Once the centre has dried out, the load shifts onto the tough outer ring, which starts to crack and tear. The disc does try to repair itself, but the breaking down keeps running ahead of the repair.","tier":"mechanistic"},{"id":"c4","text":"Two inflammatory signals, TNF-alpha and IL-1beta, do most of the driving in disc degeneration and in pain that comes from the disc itself. The disc's own cells are what make them.","tier":"mechanistic"},{"id":"c321","text":"Those same two signals coax nerve fibres to grow into a disc that in health has no nerves inside it at all.","tier":"mechanistic"},{"id":"c5","text":"In a controlled rat study, injecting TNF-alpha produced both pain and degeneration, and blocking it at the moment of injury stopped both from appearing. That makes TNF-alpha a cause and not just a marker.","tier":"preclinical"},{"id":"c6","text":"TNF-alpha tips the disc's building-and-breaking balance towards breaking. It raises the enzymes that chew up the disc's scaffolding, called MMPs, faster than it raises the TIMPs that hold those enzymes back.","tier":"mechanistic"}]}],"question_graph":{"slug":"bpc-157-vs-nsaids","questions":[],"evidence":[],"edges":[],"counts":{"questions":0,"evidence":0,"edges":0}},"honesty":{"active_claims":70,"retracted_claims":0,"cut_claims":0,"challenges":0,"scrub_events":0,"note":"Retracted/cut claims stay on ledger but are excluded from ask unless ?include_inactive=1"},"counts":{"claims":70,"claims_total":70,"sources":42,"anecdotal":17,"scientific":24,"user_reports":0,"questions":0,"evidence_ingests":0}}